Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 23, 2026
Why Is Paychex (PAYX) Stock Down -8.46% Today?

Why Is Paychex (PAYX) Stock Down -8.46% Today?

Key Takeaways

  • Shares fell roughly 8.5% after Paychex reported fiscal first-quarter 2027 results that revealed a sharp slowdown in revenue growth.
  • Primary catalyst: The core Management Solutions segment missed revenue expectations, growing just 4% and underscoring deceleration from the prior quarter's 12% growth.
  • Secondary driver: Full-year guidance was left unchanged, disappointing investors who had hoped for an upward revision.
  • Broader context: Major U.S. indices were only modestly lower, confirming that the selloff was company-specific rather than macro-driven.
  • What to watch: Integration of the Paycor acquisition, margin trajectory, and any follow-through on the company's AI initiatives.

Opening Summary

Paychex, Inc. (PAYX), the Rochester, New York-based provider of payroll, human resources, and human capital management solutions for small and medium-sized businesses, saw its shares slide sharply on Tuesday. The stock traded down about 8.5% to near $104.84, compared with a prior-session close of $114.53. The decline followed the company's fiscal 2027 first-quarter earnings release, which showed revenue growth cooling to roughly 6% year over year and its flagship Management Solutions segment falling short of Wall Street's expectations.

Earnings Results and Guidance

The market reaction centered on the pace of growth rather than the headline figures. Paychex reported first-quarter revenue of approximately $1.63 billion, roughly in line with consensus estimates, while adjusted earnings per share of $1.34 came in slightly ahead of the $1.32 analysts had projected. On the surface, the quarter appeared solid. Beneath the surface, however, the story was more concerning for investors.

Revenue growth slowed to about 6% year over year, a meaningful deceleration from the 12% growth recorded in the prior quarter. The slowdown was most visible in the Management Solutions segment, the company's core payroll and HR business, which grew just 4% to roughly $1.21 billion and missed the approximately $1.23 billion consensus estimate. That shortfall, in the segment that defines the company's franchise, became the focal point of the selloff.

Unchanged Guidance Weighs on Sentiment

Compounding the disappointment, management reiterated its full-year outlook rather than raising it. Paychex maintained its forecast for total revenue growth of 5% to 6% and adjusted diluted EPS growth of 7% to 9%. While the company did nudge up its expectations for PEO and Insurance Solutions revenue growth and interest on funds held for clients, the unchanged top-line guidance signaled that the business is not expected to re-accelerate meaningfully in the near term. For a stock trading at a premium valuation, in-line results and a hold-the-line outlook were not enough to satisfy investors who had set a high bar heading into the report.

Segment Performance and the Paycor Integration

The quarter highlighted a divergence within Paychex's business mix. PEO and Insurance Solutions delivered strong double-digit growth of about 12%, aided by a larger base of average worksite employees and higher insurance volumes. That strength, however, was offset by the slower-growing Management Solutions unit. Investors are also watching the integration of Paycor, the acquisition completed to broaden Paychex's up-market reach. Acquisition-related amortization and integration costs continued to weigh on reported results, even as they are excluded from adjusted figures, and questions remain over how quickly the deal will translate into measurable cross-selling benefits and margin expansion.

Market Context and Trading Activity

The decline in PAYX was largely idiosyncratic. Broader U.S. equities were only modestly lower during the session, with the major indices posting marginal declines, indicating that the move was driven by company-specific factors rather than a broad risk-off environment. Trading activity was elevated relative to the stock's typical volume as investors repositioned following the earnings release. The drop pushed shares well below recent trading ranges and toward the lower end of their multi-month band, breaking through short-term technical support as the selling accelerated from premarket trading into the regular session.

What Comes Next for PAYX

Looking ahead, investors will focus on whether Paychex can reignite growth in its Management Solutions segment and demonstrate tangible progress integrating Paycor. Key data points include upcoming payroll and employment trends, which influence client demand, as well as the trajectory of interest income on client funds, a line item sensitive to short-term interest rates. The company's AI initiatives, including its WISE engine and the newly launched WISE Hire recruiting tool, will also be watched for signs they can drive product penetration and client retention. Risks include persistent competition in a fragmented HCM market, any further slowdown in small-business hiring, and the potential for acquisition-related costs to continue pressuring margins.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots that monitor thousands of tickers, each calibrated to different strategies, timeframes, and performance metrics. Rather than presenting every available bot, Tickeron curates only the strongest performers under current market conditions into its dedicated Trending AI Robots section. These featured bots vary by traded symbol and approach, giving traders a focused view of which automated strategies are currently demonstrating resilience. Explore the Trending AI Robots page to discover the strategies leading the market today.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PAYX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


PAYX's Stochastic Oscillator remains in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where PAYX advanced for three days, in 175 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

PAYX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 129 of 238 cases where PAYX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.

Bearish Trend Analysis

The 10-day RSI Indicator for PAYX moved out of overbought territory on August 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 13 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PAYX as a result. In 37 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.

The Moving Average Convergence Divergence Histogram (MACD) for PAYX turned negative on August 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 27 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.

PAYX moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PAYX crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 59%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PAYX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.074) is normal, around the industry mean (51.950). P/E Ratio (23.746) is within average values for comparable stocks, (82.426). Projected Growth (PEG Ratio) (2.051) is also within normal values, averaging (3.152). Dividend Yield (0.039) settles around the average of (0.011) among similar stocks. P/S Ratio (6.452) is also within normal values, averaging (70.180).

The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PAYX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PAYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Datadog (NASDAQ:DDOG), Intuit (NASDAQ:INTU), Atlassian Corp (NASDAQ:TEAM), Workday (NASDAQ:WDAY), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.03B. The market cap for tickers in the group ranges from 39 to 242.54B. SAPGF holds the highest valuation in this group at 242.54B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 11%. SECZ experienced the highest price growth at 63%, while MYSE experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
PAYX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of payroll processing and other human resources services

Industry PackagedSoftware

Industry
Data Processing Services
Address
911 Panorama Trail South
Phone
+1 585 385-6666
Employees
17600
Web
https://www.paychex.com
Interact to see
Advertisement
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.